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Modeling study of human renal chloride channel (hCLC-5) characterised by low-molecular-weight (40 kD) pro-
mutations suggests a structural-functional relationship. teinuria (e.g., 1 and 2 microglobulinuria), hypercalci-Background. Dent’s disease, a renal tubular disorder char- uria, nephrocalcinosis, nephrolithiasis, and progressiveacterized by low-molecular-weight proteinuria, hypercalciuria,
renal failure. In addition, other renal proximal tubularand nephrolithiasis, is due to inactivating mutations in the
X-linked renal-specific chloride channel, hCLC-5. The x-ray defects, which include aminoaciduria, phosphaturia, gly-
crystal structures of two bacterial chloride channels (CLCs) cosuria, kaliuresis, uricosuria, and an acquired impair-
have recently been established, thereby allowing us to construct ment of urinary acidification may also occur [3, 4]. CLCN5,a model for hCLC-5 and further examine the role of its muta-
which in humans is expressed predominantly in the kid-tions.
Methods. The data regarding 49 hCLC-5 mutations were ney, belongs to the family of mammalian voltage-gated
reviewed. Thirty-four mutations that predicted absent or trun- chloride channel genes (CLCN1 to CLCN7, CLCKa and
cated channels were excluded. The remaining 15 mutations CLCKb) that encode proteins (CLC-1 to CLC-7, CLC-(one in-frame insertion and 14 missense mutations), 12 of which
Ka and CLC-Kb) with transmembrane domains. Heter-have been studied electrophysiologically, were assessed. The
hCLC-5 sequence was aligned with the Salmonella typhimurium ologous expression of six of the mammalian chloride
and Escherichia coli sequences and used to map the hCLC-5 channels (CLC-1 to CLC-5, and CLC-Ka) and that of
mutations onto a three-dimensional model.
the fish Torpedo marmorata (CLC-0) has demonstratedResults. hCLC-5 is a homodimeric protein, with each subunit
conductance of chloride (Cl) and other anions (e.g., I,consisting of 18 helices. None of the missense mutations in-
volved the chloride (Cl) selectivity filter, but 12 of the 15 Br, NO3 , and glutamate [5–7]. These chloride channels
mutations were found to be clustered at the interface of the are important in the control of membrane excitability,
two subunits. Six of these mutations occurred in two of the
the regulation of cell volume, and transepithelial trans-helices that either form part of the interface or lie in close
port. For example, human CLC-5 (hCLC-5), which isproximity to the interface, and three other mutations that did
not lead to complete loss of Cl conductance were at the edge expressed at multiple sites in the human nephron, includ-
of the interface. ing the proximal tubules (PT), the thick ascending limb
Conclusion. These results demonstrate a crucial role for the
(TAL) of the loop of Henle, and the -intercalated cellsinteraction between the two subunits at the interface of the
of the collecting ducts (CD) [8] is involved in transepithe-homodimeric hCLC-5.
lial solute transport (e.g., the receptor-mediated endo-
cytic pathway of the PT cells). Indeed, the renal tubular
Mutations in the renal-specific chloride channel gene abnormalities observed in patients with Dent’s disease
(CLCN5) located on chromosome Xp11.22 result in are consistent with a functional loss of CLC-5 in such a
Dent’s disease [1, 2], which is a renal tubular disorder reabsorptive pathway, and heterologous expression in
Xenopus oocytes of the mutant hCLC-5s associated with
1 These authors contributed equally to this work Dent’s disease has been shown to abolish or markedly
reduce Cl conductance [9–13]. However, it has not beenKey words: X-linked renal disease, nephrolithiasis, proteinuria, renal
failure, tubular dysfunction, Dent’s disease. possible to establish correlations between the type of
hCLC-5 mutation (e.g., premature truncation or mis-
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clinical features. We postulated that the three-dimen- 2003 by the International Society of Nephrology
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Fig. 1. Sequence alignment of CLC channels to illustrate locations of hCLC-5 missense mutations (triangles) associated with Dent’s disease. The
numbering corresponds to Salmonella typhimurium sequence (StCLC, GenBank number AE008704), and the regions of 100% identity or high
homology between this, the Homo sapiens (hCLC-5, NM_000084) and Escherichia coli (EcCLC, NC_000913) CLC channels, are highlighted in
black and gray boxes, respectively. The secondary structure (helices A to R) is shown above the sequences, and the residues forming the chloride
ion selectivity filter (see Fig. 3) are indicated by stars (residues 106 to 110, 146 to 150, 356 to 360, and 445). StCLC and EcCLC each consist of
473 residues, while hCLC-5 consists of 746 residues. Insertions that are larger than ten residues were removed from the alignment (shown by
XXX). This alignment has minor differences from that previously reported [14]. The figure was generated with ESPript [32].
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Fig. 2. Schematic representation of 47 of the 49 hCLC-5 mutations [9 to 13, 16 to 24]. hCLC-5 consists of 18  helices, A to R, which are indicated
by the boxed areas, with the cytoplasmic region below and the extracytoplasmic region above. hCLC-5 was previously considered to have 13
helical transmembrane domains [5, 9], and the residues forming these are represented in gray. It is important to note that the sequence homology
for helix A, which in the bacterial CLC is not inserted into the membrane [14, 33] is low and, thus, helix A of hCLC-5 is represented as an
approximation (dotted box). Every 50th amino acid of the 746 amino acid hCLC-5 and the consensus phosphorylation (arrow heads) and
glycosylation (branch) sites at codons 349, 350, and 408, respectively, are indicated. The residues involved in forming the chloride ion selectivity
filter (pore) [14] are indicated by asterisks, and the hCLC-5 mutations reported in patients with Dent’s disease are shown in black. The two
remaining mutations, which are complete deletions of CLCN5, are not shown [9, 16].
sional structure of hCLC-5 may provide additional in- METHODS
sights about the roles of these mutations and their associ- hCLC-5 mutations
ated phenotypes. The recent characterization of the
The published data [9–13, 16–24] regarding the 49crystal structures of homologous CLCs from Salmonella
hCLC-5 mutations associated with Dent’s disease wereenterica serovar typhimurium (StCLC) and Escherichia
reviewed with respect to type and electrophysiologiccoli (EcCLC) [14] has enabled us to explore this further.
functional effects following heterologous expression inAnalysis of the three-dimensional structures of these two
Xenopus oocytes. We specifically selected the electro-bacterial CLCs revealed that they function as homodi-
physiologic data from the Xenopus oocyte experiments,mers. Each subunit is roughly an equilateral triangle with
as these are the most comprehensive and, indeed, onlya pore at its center and the diamond-shaped homodimer
data available for mutant hCLC-5 expression. However,is formed by an edge-to-edge interaction between the
it is important to note that extrapolation of these findingstriangles. Four helices from each subunit make the main
from Xenopus oocytes to the more complex situationcontribution to the extensive symmetric interface region,
that exists in polarized PT cells, where the mutant CLC-5yielding a “double-barrelled” structure [14, 15]. In order
may be misfolded and not reach its target on the endoso-to investigate possible structural-functional relation-
mal membrane [8], requires cautious interpretation.ships, we performed studies to define the likely positions
Thus, the 49 selected mutations consisted of 10 nonsense,within the three-dimensional structure of the hCLC-5
mutations associated with Dent’s disease. 6 splice-site, 2 frameshift insertions, 11 frameshift dele-
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Table 1. Human hCLC-5 missense mutations associated with Dent’s hCLC-1 mutations were used to facilitate a comparison
disease and their corresponding residues in StCLC that were used between hCLC-1 and hCLC-5 (details available on re-
to determine locations in the secondary structure
quest).
Numbera hCLC-5b StCLC residuec Helical locationd Reference
hCLC-5 structural analysis1 G57Ve I35 B [11]
2 L200R G137 E [9] The amino acid sequences of hCLC-5 (GenBank
3 S244L A179 G [9]
number NM_000084), StCLC (AE008704), and EcCLC4 S270R R205 H to I loop [23]
5 L278Fe I215 I [12] (NC_000913) were aligned using CLUSTAL W [27] with
6 R280Pe A217 I [10] subsequent manual adjustments. At the N-terminus, where
7 G506E G393 O [9]
the sequence identity is low, a tentative alignment was8 G512R A399 O [11]
9 G513Ef A400 O [16] based on the secondary structure prediction of a helical
10 R516Wf R403 O to P loop [16] region using PSIPRED [28]. For the whole alignment,
11 S520P T407 P [9]
the sequence identity between hCLC-5 and StCLC was12 I524Kf E414 P [24]
13 E527D L411 P [11] 22% overall, and 26% for residues 94 to 410 (numbering
14 W22G —g Ag [22] refers to StCLC). The equivalent identities between
15 30insHe —g Ag [11]
hCLC-5 and EcCLC were 24% and 27%, respectively.
a Mutation number as indicated in Figure 3 The level of conservation was quite evenly distributedb Amino acid shown by one letter code: A, Ala; D, Asp; E, Glu; F, Phe; G,
Gly; H, His; I, Ile; K, Lys; L, Leu; P, Pro; R, Arg; S, Ser; T, Thr; V, Val; W, along the whole sequence, and at this level of identity,
Trp; ins, insertion the major secondary structural features would be ex-c Corresponding residue in StCLC
d Helices as shown in Figures 1 and 2 pected to be conserved, thereby making it possible to
e hCLC-5 showing 50% to 70% reduction in channel activity as compared with use the StCLC structure as a model for hCLC-5. Usingwild-type when heterologously expressed in Xenopus oocytes
f Functional studies not performed these alignments, the 13 hCLC-5 missense mutations
g Located in the amino terminus portion of helix A whose position has not (Table 1) associated with Dent’s disease were mappedbeen well characterized
onto the StCLC sequence (Fig. 1) and analyzed with
respect to its three-dimensional structure.
tions, 3 intragenic deletions (resulting in loss of exons
RESULTS4, 5, 6, 7, and 8), 2 complete deletions of the gene, 1 in-
An examination of the sequence alignments offrame insertion, and 14 missense mutations (Figs. 1 and
hCLC-5, StCLC, and EcCLC (Fig. 1) together with the2). Thirty-four of these 49 hCLC-5 mutations are either
secondary structures for the latter two channels (Fig. 2),deletions, nonsense, splice-site or frameshift mutations
suggested that the topology of hCLC-5, which has beenthat, if translated, would predict absent or truncated
previously thought to have 12 to 13 helices forming trans-channels and which have been shown to abolish Cl
membrane domains [5, 9], needed to be revised to oneconductance when expressed in Xenopus oocytes [9–13].
containing 18 helices, labeled A to R in Figures 1 andSuch truncated and inactivated channels were not ana-
2. Interestingly, 13 of the 15 (i.e., 87%) hCLC-5 missenselyzed further as they were considered unlikely to yield
mutations are located within the 18  helices. This is inuseful information in our analysis of the relationships
marked contrast (2  5.8, P  0.02) to the situation forbetween structure and function. The study focused on
truncating hCLC-5 mutations, in which only 16 of thethe remaining 15 hCLC-5 mutations (14 missense and
32 (i.e., 50%) are located in the helices. Indeed, the1 in-frame insertion, Table 1) that were predicted, if
truncating hCLC-5 mutations are scattered throughouttranslated, to yield full-length hCLC-5 proteins that ei-
the channel with no apparent hot spots [9–13, 16–24].ther reduced or abolished Cl currents [9–12, 16, 22–24].
An inspection of the hCLC-5 tertiary structure (Fig. 3)Two of these mutations (W22G and 30insH) were further
and the locations of these missense mutations (Table 1)excluded from analysis, as they are located in the N-ter-
minal region [11, 22], which is poorly conserved between reveal four additional findings of interest. First, all except
one (L200R) of the hCLC-5 missense mutations are athCLC-5, StCLC, and EcCLC, thereby rendering the se-
quence alignment unreliable. Thus, our analysis of the or near the dimer interface. This clustering of mutations
near the interface was unexpected and could not havestructure and function relationships was based on the
remaining 13 missense mutations (Table 1) and this in- been predicted from the secondary structure of the chan-
nel alone. The only missense hCLC-5 mutation not oc-cluded three mutations (G513E, R516W, and I524K),
which are known to cause Dent’s disease, but which curring at the interface is L200R, and this is predicted
to disrupt helix E (Fig. 3). The role of helix E in hCLC-5have not been functionally assessed for Cl conductance
[16, 24]. A similar analysis of the 66 published hCLC-1 function remains to be elucidated, but it is of note that
the L200R mutation results in a loss of Cl conductancemutations [25], associated with Thomsen and Becker
myotonias [26] was also undertaken and the 41 missense and a disease phenotype that is indistinguishable from
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Fig. 3. Three-dimensional model of the hCLC-5 dimer based upon the structure of StCLC dimer [14] showing the locations of missense mutations
associated with Dent’s disease. Views of the hCLC-5 dimer [stick (A ) and ribbon (B ) representations] from the extracytoplasmic side. The two
subunits are shown in blue and red with a Cl ion (large green sphere) located in the pore of each subunit. The locations of the mutated residues
are shown by the smaller yellow spheres (A) and the number beside each refers to the missense mutation shown in Table 1. Helices O and P,
which harbor 40% of the missense mutations (Fig. 2) are shown in green (B), and helices B and I, which harbor mutations that do not abolish
channel function but reduce it by 70% are shown as yellow ribbons (B). View of hCLC-5 dimer (C ) (stick model) from within the membrane
with the extracytoplasmic surface above. The channel is rotated by 90 about the x- and y-axes relative to (A). The black line (35 A˚) indicates
the approximate thickness of the membrane. N and C indicate the amino and carboxy termini of each subunit, respectively. Note that 12 of the
13 missense mutations cluster at the interface of the two subunits. This figure was prepared with Bobscript [29] and Raster 3D [30].
that of the other mutations [9]. Second, none of the helix P, whose sequence is highly conserved across the
members of the CLC family (20% identity, 73% conser-missense mutations alters the amino acids from the four
helices (D, F, N, and R) (Fig. 2) that are brought together vative changes between hCLC-5, StCLC, and EcCLC),
is one of the four major helices (H, I, P, and Q) that arenear the channel center to form the Cl selectivity filter
(Figs. 2 and 3). Third, more than 40% of the missense involved in the formation of the interface (Fig. 3). Fourth,
the three missense mutations, G57V, L278F, and R280Pmutations are found in helices O and P, or the interven-
ing loop (Table 1), thereby emphasizing the importance (Table 1), which, unlike the other 12 mutations, are not
associated with a complete abolition of Cl currents, butof this region as a hot spot for such mutations. Indeed,
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